everyone should be familiar with the recent acquisition of UK based Domantis
this company is similarly structured to PYC however the critical difference is that their drug library is antibody based
the informed PYC trader will be aware that the Phylomer technology is in many respects superior to drugs in an antibody form - better delivery, easier to manufacturer, less side effects etc.
here comes the crunch - GSK bought Domantis for $575 million aussie... PYC's current market cap is ~$40 million...
go figure
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.005(0.37%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $211.9K | 152.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4103 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 2028 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |